Our mRNA Platform
Aegis
Nuntius
Mathusalem
Fastigium
Our Business Model
Partnership
Out-licensing
About Us
Contact Us
News
Our mRNA Platform
Aegis
Nuntius
Mathusalem
Fastigium
Our Business Model
Partnership
Out-licensing
About Us
Contact Us
News
OST Group becomes a shareholder in July 2019
posted Jul 08 2019
©copyright 2016
Coqpit
Home
Aegis™ Biotechnology
Nuntius
Mathusalem
Partnership
Out-licensing
Contact Us
About Us
Recent Search Keywords
News
Messenger Biopharma licenses its Nuntius biotechnology to mRNA players
October 28, 2024
OST Group becomes a shareholder in July 2019
July 08, 2019